Aspiriant LLC’s Xtrackers MSCI Europe Hedged Equity ETF DBEU Stock Holding History

Aspiriant LLC’s Portfolio DBEU Stock Details DBEU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,773	Closed	-$372K	–	234
2018 Q4	$372K	Hold	14,773	–	–	0.03%	165
2018 Q3	$422K	Sell	14,773 -3,967	-21%	-$113K	0.04%	165
2018 Q2	$526K	Hold	18,740	–	–	0.05%	154
2018 Q1	$514K	Buy	+18,740	New	+$527K	0.04%	152
2017 Q4	–	Sell	-18,740	Closed	-$531K	–	104
2017 Q3	$531K	Hold	18,740	–	–	0.04%	136
2017 Q2	$513K	Hold	18,740	–	–	0.04%	143
2017 Q1	$507K	Hold	18,740	–	–	0.04%	145
2016 Q4	$475K	Hold	18,740	–	–	0.04%	138
2016 Q3	$483K	Buy	+18,740	New	+$475K	0.05%	139
2016 Q2	–	Sell	-436,164	Closed	-$10.8M	–	181
2016 Q1	$10.8M	Buy	+436,164	New	+$10.6M	1.03%	15

Other funds holding DBEU

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

IndexIQ Advisors New York $2.82B AUM 12.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Aspiriant LLC's DBEU Position: Q1 2019 in Review

Aspiriant LLC sold out of Xtrackers MSCI Europe Hedged Equity ETF (DBEU) in Q1 2019, closing a stake of 14,773 shares — an estimated $372K sold.

Aspiriant LLC first reported a position in DBEU in Q1 2016 and held it in 10 quarters. The position peaked at $10.8M in Q1 2016. 90 funds tracked by Wall St. Rank hold DBEU as of Q1 2019.

Aspiriant LLC reported no remaining Xtrackers MSCI Europe Hedged Equity ETF position as of Q1 2019 after selling out during the quarter.
Aspiriant LLC sold 14,773 Xtrackers MSCI Europe Hedged Equity ETF shares in Q1 2019, an estimated $372K.
Aspiriant LLC first reported a position in Xtrackers MSCI Europe Hedged Equity ETF in Q1 2016 and held it in 10 quarters.
Aspiriant LLC's Xtrackers MSCI Europe Hedged Equity ETF position peaked at $10.8M in Q1 2016.
90 funds tracked by Wall St. Rank held Xtrackers MSCI Europe Hedged Equity ETF as of Q1 2019.

Based on Aspiriant LLC's 13F filing for Q1 2019, filed 3 May 2019.